Ticker > Company >

Fischer Medical share price

Fischer Medical Ventures Ltd.

NSE: FISCHER BSE: 524743 SECTOR: Chemicals  14.61 K   19   0

93.49
-3.76 (-3.87%)
NSE: Today, 01:14 PM

Price Summary

Today's High

₹ 97.34

Today's Low

₹ 92.05

52 Week High

₹ 124.7

52 Week Low

₹ 77.01

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

6062.97 Cr.

Enterprise Value

6062.68 Cr.

No. of Shares

64.85 Cr.

P/E

0

P/B

19.66

Face Value

₹ 1

Div. Yield

0.01 %

Book Value (TTM)

₹  4.75

CASH

0.29 Cr.

DEBT

0 Cr.

Promoter Holding

61.8 %

EPS (TTM)

₹  -0.01

Sales Growth

-54.72%

ROE

0.35 %

ROCE

0.53%

Profit Growth

64.65 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-54.72%
3 Year∞%
5 Year95.26%

Profit Growth

1 Year64.65%
3 Year69.28%
5 Year78.59%

ROE%

1 Year0.35%
3 Year0.46%
5 Year0.27%

ROCE %

1 Year0.53%
3 Year2.81%
5 Year-19.63%

Debt/Equity

0

Price to Cash Flow

-251.54

Interest Cover Ratio

8.2954

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2025 61.80 0.00
Jun 2025 61.80 0.00
Mar 2025 62.81 0.00
Dec 2024 74.91 0.00
Sep 2024 74.91 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • Company has a healthy liquidity position with current ratio of 3.7013.
  • The company has a high promoter holding of 61.8%.

 Limitations

  • Company has a poor ROE of 0.456966666666667% over the past 3 years.
  • Company has a poor ROCE of 2.81483333333333% over the past 3 years
  • Company has high debtor days of 1041.1454.
  • Company has negative cash flow from operations of -24.1035.
  • The company has a low EBITDA margin of -9.3509% over the past 5 years.
  • The company is trading at a high PE of 0.
  • The company is trading at a high EV/EBITDA of 4365.7067.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 0 0 0 5.22 4.54
Total Expenditure 0.11 0.36 0.22 6.78 4.17
Operating Profit -0.11 -0.36 -0.22 -1.56 0.37
Other Income 1.12 0.82 0.87 0.65 0.8
Interest 0 0 0 0.12 1.31
Depreciation 0 0 0.03 0.1 0.08
Exceptional Items 0 0 0 0 0
Profit Before Tax 1.01 0.46 0.62 -1.13 -0.22
Tax 0.17 -0.05 0.42 -0.24 0.39
Profit After Tax 0.84 0.51 0.2 -0.89 -0.61
Adjusted EPS (Rs) 0.02 0.01 0 -0.01 -0.01

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 0.17 0 0.18 11.53 5.22
Total Expenditure 0.18 0.19 0.16 11.72 7.46
Operating Profit -0.02 -0.19 0.02 -0.2 -2.24
Other Income 0 0 0 0.75 3.46
Interest 0.02 0.01 0.02 0.02 0.13
Depreciation 0 0 0 0 0.13
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.04 -0.2 0 0.54 0.96
Tax -0.18 0.04 0.04 0.14 0.3
Net Profit 0.14 -0.23 -0.04 0.4 0.66
Adjusted EPS (Rs.) 0.82 -1.35 -0.21 0.01 0.01

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 0.17 0.17 0.17 53.5 63.8
Total Reserves -0.17 -0.4 -0.44 26.18 271.88
Borrowings 0.23 0 0 0 0
Other N/C liabilities -0.18 -0.14 -0.11 0 15.42
Current liabilities 0.02 0.42 0.62 12.18 7.56
Total Liabilities 0.08 0.05 0.25 91.86 358.67
Assets
Net Block 0 0 0 0.01 0.68
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 41.28 294.36
Loans & Advances 0 0 0 0 1.65
Other N/C Assets 0 0 0 0 34
Current Assets 0.08 0.05 0.25 50.57 27.99
Total Assets 0.08 0.05 0.25 91.86 358.67
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations -0.04 -0.2 0 0.54 0.96
Adjustment 0.02 0.01 0.02 0.02 0.15
Changes in Assets & Liabilities -0.04 0.01 -0.16 -0.43 -24.91
Tax Paid 0 0 0 -0.05 -0.31
Operating Cash Flow -0.06 -0.18 -0.15 0.08 -24.1
Investing Cash Flow 0 0 0 -37.78 -231.79
Financing Cash Flow 0 0.15 0.17 37.67 256.18
Net Cash Flow -0.06 -0.03 0.02 -0.03 0.28

Corporate Actions

Investors Details

PARTICULARS Sep 2024% Dec 2024% Mar 2025% Jun 2025% Sep 2025%
promoters 74.91 74.91 62.81 61.80 61.80
fmv holdings pte ltd - - - - 51.16
shankar varadharajan 12.90 - - - 10.64
shankar varadharajan-pref... - 12.90 10.82 10.64 -
time medical internationa... 62.01 - - 51.16 -
time medical internationa... - 62.01 52.00 - -
PARTICULARS Sep 2024% Dec 2024% Mar 2025% Jun 2025% Sep 2025%
investors 25.09 25.09 37.19 38.20 38.20
blue lotus capital multi ... 1.68 1.68 1.44 1.42 1.42
hitesh natwarlal kawa - 1.68 - - 1.19
india energing gaints fun... - - - - 2.23
kaushik hasmukhlal gandhi... 1.55 1.55 - - 1.28
natwarlal keshavjibhai ka... 1.68 1.68 1.41 1.23 1.19
nimesh sahadeo singh 1.45 1.42 1.17 1.15 1.14
roopal hitesh kawa 3.36 3.36 2.82 2.78 2.74
suriyamoorthy shanmugavel... - - 1.34 1.32 1.32
vikasa india eif i fund 2.83 2.83 2.37 2.57 2.57
vinay rajendrakumar nagda... - - 1.57 1.54 1.54
hitesh natwarlal kawa . - - 1.41 1.23 -
india emerging giants fun... - 2.24 2.24 2.29 -
kaushik hasmukhlal gandhi... - - 1.30 1.28 -
jitendra rasiklal sanghav... 1.26 1.26 - - -
hithesh natwarlal kawa 1.68 - - - -
india emerging giants fun... 2.24 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2021
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q2FY25
Presentation Q2FY25

Company News

Fischer Medical Stock Price Analysis and Quick Research Report. Is Fischer Medical an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Fischer Medical. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Fischer Medical has a PE ratio of -7663.11475409836 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Fischer Medical has ROA of 0.2944% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Fischer Medical has a Current ratio of 3.7013.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Fischer Medical has a ROE of 0.3452%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Fischer Medical has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: Fischer Medical has reported revenue growth of -54.7227% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Fischer Medical for the current financial year is -42.8626166254766%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Fischer Medical is Rs 0.05 and the yield is 0.0054%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Fischer Medical is Rs -0.0122. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Fischer Medical in Ticker for free. Also, one can get the intrinsic value of Fischer Medical by using Valuation Calculators, which are available with a Finology ONE subscription. 

Fischer Medical FAQs

Q1. What is Fischer Medical share price today?
Ans: The current share price of Fischer Medical is Rs 93.49.

Q2. What is the market capitalisation of Fischer Medical?
Ans: Fischer Medical has a market capitalisation of Rs 6062.97112903 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Fischer Medical?
Ans: The PE ratio of Fischer Medical is -7663.11475409836 and the P/B ratio of Fischer Medical is 19.6634767062783, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Fischer Medical share?
Ans: The 52-week high share price of Fischer Medical is Rs 124.7, and the 52-week low share price of Fischer Medical is Rs 77.01.

Q5. Does Fischer Medical pay dividends?
Ans: Currently, Fischer Medical pays dividends. Dividend yield of Fischer Medical is around 0.0054%.

Q6. What are the face value and book value of Fischer Medical shares?
Ans: The face value of Fischer Medical shares is Rs 1, while the book value per share of Fischer Medical is around Rs 4.7545. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Fischer Medical?
Ans: Fischer Medical has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Fischer Medical?
Ans: The ROE of Fischer Medical is 0.3452% and ROCE of Fischer Medical is 0.526%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Fischer Medical a good buy for the long term?
Ans: The Fischer Medical long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Fischer Medical undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Fischer Medical appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Fischer Medical’s financials?
Ans: You can review Fischer Medical’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Fischer Medical
X